No Carolina / New York / Florida        Ph: 561.316.3330

HomeACQUISITIONS and MERGERSSmiths Medical Acquires the Business of Access Scientific, LLC, Expanding Vascular Access...

Smiths Medical Acquires the Business of Access Scientific, LLC, Expanding Vascular Access Offering

What To Know

  • Today (May 13, 2020), Smiths Medical announced the acquisition of the business of Access Scientific, LLC, a privately-held company based in San Diego, CA.
  • “Smiths Medical's acquisition of Access Scientific enhances our commitment to patient care and outcomes, driving category leadership in our existing vascular access portfolio,” said JehanZeb Noor, Smiths Medical CEO.

Today (May 13, 2020), Smiths Medical announced the acquisition of the business of Access Scientific, LLC, a privately-held company based in San Diego, CA.

Access Scientific is a broad-spectrum vascular access and infection prevention company that manufactures the POWERWAND™ midline and extended dwell catheters. The range of POWERWAND™ products extends Smiths Medical’s vascular access product portfolio and enables greater clinician choice to treat patients.

The POWERWAND™ range of products are clinically differentiated vascular access solutions, supported by nine (9) peer-reviewed papers and nine (9) scientific posters. Bloodstream infections are a known risk associated with vascular access catheters. Conclusions from recent clinical studies show no occurrence of bloodstream infections associated with use of the POWERWAND™ products. Combined, these studies have a total of 35,000 catheter days without bacterial infections.1-3

The POWERWAND™ range of products offers value to healthcare providers looking to offer quality care for their patients. When combined with Smiths Medical’s already strong performing Jelco® IV catheter and Port-A-Cath® products, Smiths Medical now offers clinicians more solutions to treat their patients through a broader portfolio.

“Smiths Medical’s acquisition of Access Scientific enhances our commitment to patient care and outcomes, driving category leadership in our existing vascular access portfolio,” said JehanZeb Noor, Smiths Medical CEO. “We believe this acquisition enhances our position as a trusted medication management solutions company. During this time of uncertainty, we feel privileged to offer our customers on the frontlines more choices for treating their patients.”

By using this website you agree to accept Medical Device News Magazine Privacy Policy